This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder | MicrobiomeTrials
← Back to trials NCT03065335
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2017-05-25Est. Completion: 2027-01-01
Enrollment target: 150 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in Vascular And Immunologic Diseases Healthy Volunteers
Background:
Diseases involving blood, blood vessels, and immune systems are leading causes of death in the United State…
Bethesda, United States Est. completion Jan 30, 2032
Acute Ischemic Stroke
Acute ischemic stroke (AIS) is responsible for considerable morbidity and mortality worldwide and has serious medico-eco…
Tours, France Completed Dec 10, 2025
Healthy Volunteer
Background:
Many people in the United States are overweight or obese. Researchers want to learn why some people can ove…
Phoenix, United States Est. completion Jul 1, 2037